Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price purchased 2,000,000 shares of the firm’s stock in a transaction on Monday, December 22nd. The shares were purchased at an average cost of A$0.01 per share, for a total transaction of A$18,000.00.
Percheron Therapeutics Stock Performance
About Percheron Therapeutics
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Read More
- Five stocks we like better than Percheron Therapeutics
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
